These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 1597914

  • 1. Intravenous immunoglobulin therapy for toxic shock syndrome.
    Barry W, Hudgins L, Donta ST, Pesanti EL.
    JAMA; 1992 Jun 24; 267(24):3315-6. PubMed ID: 1597914
    [Abstract] [Full Text] [Related]

  • 2. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
    Perez CM, Kubak BM, Cryer HG, Salehmugodam S, Vespa P, Farmer D.
    Am J Med; 1997 Jan 24; 102(1):111-3. PubMed ID: 9209207
    [No Abstract] [Full Text] [Related]

  • 3. Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review.
    Cawley MJ, Briggs M, Haith LR, Reilly KJ, Guilday RE, Braxton GR, Patton ML.
    Pharmacotherapy; 1999 Sep 24; 19(9):1094-8. PubMed ID: 10610017
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
    Linnér A, Darenberg J, Sjölin J, Henriques-Normark B, Norrby-Teglund A.
    Clin Infect Dis; 2014 Sep 15; 59(6):851-7. PubMed ID: 24928291
    [Abstract] [Full Text] [Related]

  • 5. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J, Söderquist B, Normark BH, Norrby-Teglund A.
    Clin Infect Dis; 2004 Mar 15; 38(6):836-42. PubMed ID: 14999628
    [Abstract] [Full Text] [Related]

  • 6. [Streptococcal toxic shock syndrome or Kawasaki disease? Two case studies of children with group A streptococcal pneumonia empyema].
    Bosland A, Arlaud K, Rousset-Rouvière C, Fouilloux V, Paut O, Dubus JC, Bosdure E.
    Arch Pediatr; 2011 Dec 15; 18(12):1310-4. PubMed ID: 22041597
    [Abstract] [Full Text] [Related]

  • 7. Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.
    Lamothe F, D'Amico P, Ghosn P, Tremblay C, Braidy J, Patenaude JV.
    Clin Infect Dis; 1995 Dec 15; 21(6):1469-70. PubMed ID: 8749635
    [Abstract] [Full Text] [Related]

  • 8. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
    Sriskandan S, Ferguson M, Elliot V, Faulkner L, Cohen J.
    J Antimicrob Chemother; 2006 Jul 15; 58(1):117-24. PubMed ID: 16670109
    [Abstract] [Full Text] [Related]

  • 9. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Abinun M, Cant AJ.
    Lancet; 1994 Jan 29; 343(8892):300. PubMed ID: 7905129
    [No Abstract] [Full Text] [Related]

  • 10. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.
    Stevens DL.
    Clin Infect Dis; 1998 Mar 29; 26(3):639-41. PubMed ID: 9524836
    [No Abstract] [Full Text] [Related]

  • 11. Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature.
    Tilanus AM, de Geus HR, Rijnders BJ, Dwarkasing RS, van der Hoven B, Bakker J.
    Int J Infect Dis; 2010 Sep 29; 14 Suppl 3():e208-12. PubMed ID: 19914115
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dilemmas in the treatment of invasive Streptococcus pyogenes infections.
    Stevens DL.
    Clin Infect Dis; 2003 Aug 01; 37(3):341-3. PubMed ID: 12884157
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics.
    Chiu CH, Ou JT, Chang KS, Lin TY.
    Infection; 1997 Aug 01; 25(1):47-8. PubMed ID: 9039540
    [No Abstract] [Full Text] [Related]

  • 15. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
    Baxter M, Morgan M.
    Emerg Infect Dis; 2017 Jan 01; 23(1):127-129. PubMed ID: 27983491
    [Abstract] [Full Text] [Related]

  • 16. Case 28-2002: a traveler with a rapidly progressive soft-tissue infection.
    Johnson JR, Gandhi R.
    N Engl J Med; 2003 Jan 09; 348(2):176-7; author reply 176-7. PubMed ID: 12519934
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Puerperal widespread pyomyositis after group A streptococcal toxic shock syndrome.
    Feigenberg T, Sela HY, Applbaum YH, Mankuta D.
    Isr Med Assoc J; 2008 Jun 09; 10(6):483-4. PubMed ID: 18669156
    [No Abstract] [Full Text] [Related]

  • 19. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome.
    Schrage B, Duan G, Yang LP, Fraser JD, Proft T.
    Clin Infect Dis; 2006 Sep 15; 43(6):743-6. PubMed ID: 16912949
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of polyspecific intravenous immunoglobulin therapy in streptococcal toxic shock syndrome.
    Arends JE, Harkisoen S.
    Clin Infect Dis; 2015 Jan 15; 60(2):324. PubMed ID: 25313253
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.